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Primary  hepatocytes  are  widely  used  in investigating  drug  metabolism  and its toxicological  effects.
N-Nitrosodiethylamine  (NDEA)-induced  genotoxicity  and  cytotoxicity  was  used in  primary  cultures
of  female  rat hepatocytes  in  the  presence  of phenobarbital  (PB).  PB  pre-treatment  (1 mM)  increased
the  number  of  necrotic  (2-fold)  and  apoptotic  cells  (4-fold)  after  NDEA  treatment  (0.21–105  g/mL).
The  mitotic  indices  and  the  number  of  micronucleated  cells  decreased,  thus suggesting  cytotoxicity.
An  increased  number  of chromosomal  aberrations  were  observed  after  pre-treatment  with  PB. NDEA-enotoxicity
-Nitrosodiethylamine
epatocytes
henobarbital
ytochrome P450 isoforms
treatment  (0.21–21  g/mL)  induced  expression  of  the  CYP2B1  and  CYP2B2  mRNA  and  PB treatment
alone  induced  ∼6-fold  and  ∼2-fold  increases  of  CYP2B1  and  CYP2B2  mRNA,  respectively.  NDEA  treat-
ment  following  PB exposure  increased  CYP2B1  mRNA  expression  under  all  tested  concentrations  and
also  increased  CYP2B2  expression  at 21 and  105  g/mL.  Our  data  suggest  that  the  alteration  of CYP2B1/2
expression  by PB increased  the  cytotoxicity  and  genotoxicity  of  NDEA  leading  to  the  ﬁnal  genotoxic
metabolite.
© 2011 Elsevier Ireland Ltd. Open access under the Elsevier OA license.. Introduction
It is a generally accepted fact that the incidence of certain human
umors is strongly correlated to geographical and environmen-
al factors, including diet. The presence of N-nitrosamines in diet
robably represents the most comprehensively studied exposure
ituation for any class of genotoxic carcinogenic compounds in the
uman diet, and has been a subject of several reviews (Forman,
987; Hotchkiss, 1987, 1989; Tricker and Preussmann, 1988, 1991).
In 1993, the US Environmental Protection Agency (U.S. EPA,
993) established a cancer risk for N-nitrosodimethylamine
NDMA) of about two orders of magnitude higher than the
isk estimate by Health Canada (0.7 ng/kg bodyweight per day)
Health Canada, 2002), while the rat carcinogenic potency of
-nitrosodiethylamine (NDEA) is about three times that of
DMA (Lijinsky, 1992). In humans, the average intake of NDEA
rom food is approximately 1 g/day (Scanlan, 1983). How-
ver, NDEA is also found in cigarettes and cigarette smoke at
∗ Corresponding author: Tel.: +55 21 25876109; fax: +55 21 22849748.
E-mail address: aiub@hotmail.com (C.A.F. Aiub).
378-4274 © 2011 Elsevier Ireland Ltd. 
oi:10.1016/j.toxlet.2011.07.002
Open access under the Elsevier OA license.0.0083–0.0405 g/cigarette, as well as in rolls, buns, mufﬁns and
bagels (0.023 g/100 g), ham (0.149 g/100 g) and even oysters
(0.109 g/100 g) (Stuff et al., 2009). Thus, it is difﬁcult to predict
the exact exposure rate of individuals.
NDEA is a carcinogen that can induce tumors in a variety of
organs of many animal species (Magee and Barnes, 1956; Peto
et al., 1991; Lijinsky, 1992). It requires metabolic activation through
P450-catalyzed -hydroxylation, generating unstable metabolites
that alkylate the DNA and thus cause tumor formation (Ribeiro
Pinto, 2000). Due to their high expression levels of cytochrome
P450 (CYP), hepatocytes represent the most suitable model to
investigate CYP induction in relation to drug metabolism. In fact
it has been shown that phenobarbital (PB) induces markedly
increased expression of several phase I and II enzymes, including
several forms of cytochrome P450 (Gonzales, 1989; Waxman and
Azaroff, 1992).
In the present work we focused on CYP2B1 and CYP2B2, which
are two  of the major P450 cytochromes that are induced by
PB in rat livers. We  correlated N-nitrosodiethylamine genotox-
icity (micronuclei and mitotic index) and cytotoxicity (survival,
apoptosis, and necroses rates) in primary cultures of female rat
hepatocytes in the presence of PB.
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.  Materials and methods
.1. Animal model
Female albino Fischer 344 rats (F-344/DuCrl) of 6–8 weeks of age were used for
he  experiments (Charles River Laboratories, Germany). The light/dark regime was
2/12 h, and standard pelleted rat feed and drinking water was  supplied ad libitum.
hree female Fischer 344 rat livers were used per NDEA concentration. Nitrosamines
re able to induce liver tumors not only in male, but also in female rats (Lijinsky,
992).  The study was conducted in compliance with the National Research Council
f Austria’s “Guide for the Care and Use of Laboratory Animals”.
.2. Hepatocyte isolation and cell culture
Hepatocytes were prepared according to the two-step collagenase perfusion
ethod (Eckl and Riegler, 1997). Rats were anesthetized with 200 mg/kg sodium
entobarbital. Following hepatic portal vein cannulation, the livers were perfused
or  15 min  at a ﬂow rate of 15 mL/min with solution A (142 mM NaCl, 6.7 mM KCl,
0 mM HEPES, pH 7.4). Subsequently, the livers were perfused for 20 min  (ﬂow rate
0 mL/min) using 200 mL  solution C (buffer A and 5.7 mM CaCl2 at a ratio of 9:1) con-
aining 0.5 mg/mL  collagenase (Collagenase Sigma IV, 125 CDU/mg, CAS 9001-12-1).
he perfused livers were dispersed in 50 mL solution A, and the isolated hepato-
ytes were ﬁltered through a 180 m nylon ﬁlter and centrifuged at 500 rpm for
0 min. After repeating the washing step, the cells were resuspended in Modiﬁed
agle Medium (MEM) Ca2+, 1.8 mM,  (Gibco®) and supplemented with 5% fetal bovine
erum, 26.2 mM NaHCO3, 1 mM pyruvate, 0.2 mM aspartic acid and 0.2 mM l-serine.
fter trypan blue staining, viable hepatocytes were counted by haemocytometry,
nd 2.5 × 105 or 2.5 × 106 cells were plated on 60 mm (for genotoxicity assays) or
0 mm (for mRNA quantitation) collagen-coated dishes, respectively. Hepatocytes
ere allowed to attach for 3 h and viability was found to range from 85 to 90%. After
ttachment, the medium was  removed and replaced with fresh MEM  (Ca2+, 1.8 mM).
.3.  Incubation of cells
After replacing the MEM  (1.8 mM,  Ca2+), PB (CAS 50-06-6) (prepared in 0.9%
aCl) was  added directly to the cultures in a ﬁnal concentration of 1 mM.  After 16 h,
at  hepatocyte cultures were incubated with NDEA (CAS 55-18-5) at concentrations
anging from 0.21 to 105 g/mL (corresponding to 0.05 to 25 mM ﬁnal concentra-
ions) for 3 h. The cells were subsequently washed once with MEM,  0.4 mM,  Ca2+, and
e-incubated with MEM, 0.4 mM,  Ca2+, supplemented with 40 ng/mL EGF (Sigma)
nd 0.1 M insulin (Sigma) for 48 h. RNA was extracted after 6 h and cytogenetic
ssays were terminated after 48 h of NDEA treatment. As a positive control for
he  cytogenetic assays, the cells were treated with 0.5 M N-methyl-N′-nitro-N-
itrosoguanidine (MNNG).
.4. Cytogenetic studies
Cytogenetic studies were performed in triplicate as described by Eckl and Riegler
1997) with the following modiﬁcations. For determination of the mitotic index (the
ercentage of total cells in some stage of mitosis) and the number of micronucleated
ells, MEM (0.4 mM,  Ca2+) was replaced with cold ﬁxative methanol–glacial acetic
cid (3:1). The cells were incubated for 15 min on the petri dish, rinsed with distilled
ater for 2 min  and air dried. The ﬁxed cells were stained with 4′-6-diamidino-
-phenylindole (DAPI) using a solution of 0.2 g/mL dissolved in McIlvaine buffer
0.1  M citric acid, 0.2 M Na2HPO4, pH 7.0) for 40 min. After washing with McIlvaine
uffer for 2 min, the cells were brieﬂy rinsed with distilled water and mounted in
lycerol.
To  determine the mitotic index and number of cells with micronuclei, 1000 cells
er petri dish (2000 cells per animal/group concentration) were analyzed under the
uorescence microscope (Reichert Univar) at an excitation wavelength of 350 nm.
he micronucleus results are presented as a percentage of cells containing micronu-
lei  in 2000 total cells/group concentration analyzed.
The presence of glowing bright and homogenous nuclei in cells was considered
he normal phenotype morphology. Apoptotic nuclei were identiﬁed by condensed
able  1
rimer sequences of oligonucleotides used for real-time quantitative PCR.
Gene/GenBank entry Tm (◦C) Primer 
18S RNA (V01270) 67.5 Forward 
69.5  Reverse 
CYP2A1 (J04187) 68.1 Forward 
69.5  Reverse 
CYP2B1 (AJ320166) 68 Forward 
66.4  Reverse 
CYP2B2 (J00720) 66.1 Forward 
68.3  Reverse 
CYP2E1 (J02627) 66.8 Forward 
63.7  Reverse ters 206 (2011) 139– 143
chromatin gathering at the periphery of the nuclear membrane or by fragmented
nuclear body morphology.
Necrotic cells presented chromatin that formed irregularly shaped aggregates, a
pyknotic nucleus (shrunken and darkly stained) and membrane cell disruption with
cellular debris spills into the extracellular milieu. Two  thousand cells were counted
and values of apoptotic and necrotic cells are given as percentages.
For the determination of chromosomal aberrations, we added 0.4 g/mL col-
cemide to the dishes (triplicate/animal/NDEA group concentration) and incubated
the  cells for a further 3 h. The medium was replaced by 2 mL  collagenase solution
(0.5 mg/mL) and incubated for 10 min in order to detach the cells. The cells were col-
lected by centrifugation, and 0.01 M KCl hypotonic solution was added for 10 min.
The cells were ﬁxed overnight in cold methanol–glacial acetic acid (3:1) by dropping
the  suspension on glass slides. Five slides were prepared for each animal and NDEA
group concentration.
The slides were stained for 15 min  using 4.5 g/mL Hoechst 33258, rinsed with
distilled water, mounted in PBS, pH 7.0, with a coverglass, and exposed to a 40 W
blacklight lamp (Philips TLD 36W08) at 50 ◦C for 1 h. After removing the coverslips,
the  slides were stained with 5% Giemsa solution. Chromosomal aberrations were
scored using 50 well-spread metaphases, and aberration numbers were given per
diploid cell, i.e. 42 chromosomes. Metaphases were scored for chromosome-type
aberrations, such as chromosome deletions, dicentrics and ring chromosomes. The
data were analyzed by one-way analysis of variance (ANOVA) and the results were
considered statistically signiﬁcant at p < 0.05.
2.5.  RNA isolation
Total RNA was  isolated with TRIzol (Invitrogen, Germany) and treated with
0.5 units DNase I (Invitrogen) according to the manufacturer’s instructions. DNA-free
RNA was  dissolved in DEPC water and stored at −80 ◦C.
2.6. cDNA synthesis
First-strand cDNA synthesis was performed using an oligo dT primer (0.3 ng/L)
and  SuperscriptTM III bulk mix  (Invitrogen) according to the manufacturer’s instruc-
tions.
2.7.  Primer design for ampliﬁcation of CYP subfamilies
The DNA coding sequences of CYP genes were obtained from GenBank
(http://www.ncbi.nml.nih.gov/GenBank), and the entry codes are given in Table 1.
A  subfamily-speciﬁc DNA region was selected as the site of hybridization for each
CYP for the design of either the forward or the reverse primer. The corresponding
oligonucleotide was  selected for ampliﬁcation on the basis of (i) similar melting
temperatures, (ii) similar nucleotide length, and (iii) generation of an amplicon with
at  least 50% GC content. To control speciﬁcity, all the primers were submitted to the
basic logarithmic alignment search tool (BLAST).
2.8. Quantitative real-time PCR
Quantitative RT PCR was done using the BioRad iCycler iQ Real-Time Detection
System (BioRad) according to the manufacturer’s instructions. A cycle threshold (CT)
is  deﬁned as the cycle number at which the ﬂuorescence generated within a reaction
is  signiﬁcantly higher than the background value, and is inversely proportional to the
relative expression level of a gene. Average CT values from duplicate PCR reactions
were normalized to CT values of housekeeping genes for each cDNA preparation
(CT). The ratio of drug-induced and spontaneously induced CYP gene expression
was calculated as CT. The fold induction of each CYP gene was calculated as
−(CT)2 , as recommended by Perkin-Elmer. Values were reported as the average of
the triplicate analyses. The amount of each gene target in different groups was  nor-
malized to an endogenous control (18S ribosomal RNA). For the statistical analysis
the  “Relative Expression Software Tool” (REST 2005, 2008) was used to estimate up-
and down-regulation for the gene expression studies (95% conﬁdence interval).
Sequence Amplicon bp
AGTCCCTGCCCTTTGTACACACCGC 152
ACCATCCAATCGGTAGTAGCGACGGG
TCAATCCTCACTGGCCACTATGCTGGACA 90
CAGAGGGACACCAAGAGCATGACGCTC
CAGCCAGGTGTTTGAGTTCTTCTCTGGG 122
CCCTGTGCTTCTCCACAATATGGCCA
ACATGTGAACAGAGATTTCATGAGTACACATCTCAT 148
TGTAGACATAGCACTGAGACCATATACAGAGTCCAT
CTCCTCGTCATATCCATCTGGAAGAAGATCT 127
TGGTGAAAGACTTGGGGATATCCTTCAA
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Table 2
Effect of PB (1 mM)  pretreatment on NDEA cytotoxicity.
Inducer Assay conditions % Survival % Necrosis % Apoptosis
W/o  NaCl 0.9% 98.7 ± 0.3 1.1 ± 0.4 0.2 ± 0.1
NDEA 0.21 g/mL 98.2 ± 0.4 1.6 ± 0.3 0.2 ± 0.1
NDEA 2.1 g/mL 97.4 ± 0.5* 2.4 ± 0.5* 0.2 ± 0.1
NDEA 21 g/mL 97.2 ± 0.7* 2.4 ± 0.6* 0.4 ± 0.2
NDEA 105 g/mL 97.2 ± 1.0 2.5 ± 1.0 0.4 ± 0.1*
PB NaCl 0.9% 98.0 ± 0.2 1.3 ± 0.1 0.8 ± 0.1††
NDEA 0.21 g/mL 97.9 ± 0.5 1.5 ± 0.3 0.7 ± 0.2†
NDEA 2.1 g/mL 93.8 ± 0.3**,†† 4.8 ± 0.5*,† 1.4 ± 0.2*,††
NDEA 21 g/mL 93.4 ± 0.4**,†† 4.7 ± 0.1**,† 2.4 ± 0.4*,††
NDEA 105 g/mL 92.9 ± 0.4**,† 3.6 ± 0.3* 3.6 ± 0.1**,††
MNNG 0.5 M 61 ± 12 8 ± 0.3 31 ± 12
Mean ± SEM of 3 female Fischer 344 rat livers. 2000 cells were analyzed per ani-
mal/NDEA group concentration.
* Statistically signiﬁcant differences compared to the respective control (0.9%
NaCl or PB): p < 0.05.
** Statistically signiﬁcant differences compared to the respective control (0.9%
NaCl or PB): p < 0.01).
† Statistically signiﬁcant differences between PB treated and untreated cultures:
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Table 4
Mean values for chromosomal aberrations per cell in female Fischer 344 rat hepa-
tocytes after NDEA (0.21–105 g/mL) treatment and PB (1 mM)  pre-treatment.
Inducer Assay conditions Chromosome damage
Deletions/
breakage
Dicentrics Rings Total
W/o  NaCl 0.9% 1.23 0.36 0.64 2.23 ± 1.30
NDEA 0.21 g/mL 1.42 1.26 0.47 3.15 ± 1.70
NDEA 2.1 g/mL 0.94 2.37 0.63 3.94 ± 0.90
NDEA 21 g/mL 1.47 3.53 0.41 5.41 ± 0.21*
NDEA 105 g/mL 1.20 2.50 0.30 4.00 ± 00
PB  NaCl 0.9% 0.80 2.45 0.10 3.35 ± 0.21
NDEA 0.21 g/mL 0.31 4.69 0.44 5.44 ± 0.28*
NDEA 2.1 g/mL 1.05 3.81 0.14 5.00 ± 0.07*
NDEA 21 g/mL 1.88 4.47 0.12 6.47 ± 0.07*
NDEA 105 g/mL 2.00 7.16 0.50 9.66 ± 2.50*,†
MNNG 0.5 M 9.34* 2.06* 3.27* 14.67 ± 3.45*
Mean ± SEM of 3 independent experiments.
*
increasing doses of NDEA (Table 5). Treatment with NDEA alone
induced a signiﬁcantly increased expression of CYP2B1 at a low
concentration (0.21 g/mL), while CYP2B2 and CYP2E1 expression
was up-regulated at concentrations ranging from 0.21 to 21 g/mL
Table 5 < 0.05.
†† Statistically signiﬁcant differences between PB treated and untreated cultures:
 < 0.01.
.9. Statistical analysis
When the p-values from one-way ANOVA test statistic were statistically signif-
cant (p < 0.05), post-hoc Tukey multiple comparison test were used to determine
hich groups differ from which others. ANOVA is singling as *, and Tukey with †  in
he  tables.
. Results
.1. Cytogenetic studies
NDEA cytotoxicity induced in the presence or absence of PB
reatment is shown in Table 2. Upon pre-treatment with PB, the
nduction of necrosis was twofold higher at 2.1 and 21 g/mL NDEA,
nd ninefold higher for apoptosis at 105 g/mL NDEA.
A signiﬁcant decrease in the number of micronucleated cells and
itotic indices (Table 3) was detected at NDEA concentrations of
1 and 105 g/mL in the absence of PB, and at NDEA concentra-
ions of 105 g/mL in the presence of PB. In the absence of NDEA,
B pre-treatment reduced the mitotic index and consequently the
umber of micronucleated cells. The decrease in the number of
able 3
ffect of PB (1 mM)  pretreatment on NDEA genotoxicity.
Inducer Assay conditions Mitotic index (%) Micronuclei cells (%)
W/o  NaCl 0.9% 4.2 ± 1.1 9.3 ± 2.3
NDEA 0.21 g/mL 4.1 ± 0.0 11.7 ± 4.2
NDEA 2.1 g/mL 4.2 ± 0.4 17.3 ± 2.3*
NDEA 21 g/mL 2.3 ± 0.6 6.0 ± 2.6
NDEA 105 g/mL 1.1 ± 0.6* 3.3 ± 0.6*
PB NaCl 0.9% 0.9 ± 0.1† 2.5 ± 0.2†
NDEA 0.21 g/mL 1.3 ± 0.1*,†† 2.2 ± 0.1
NDEA 2.1 g/mL 2.0 ± 0.1**,†† 3.1 ± 0.2††
NDEA 21 g/mL 1.5 ± 0.6†† 4.9 ± 0.2*
NDEA 105 g/mL 0.4 ± 0.2 1.7 ± 0.3†
MNNG 0.5 M 1.8 ± 3.0* 18 ± 2.7*
ean ± SEM of 3 female Fischer 344 rat livers. 2000 cells were analyzed per ani-
al/NDEA group concentration.
* Statistically signiﬁcant differences compared to PB pre-treatment (0.9% NaCl or
B):  p < 0.05.
** Statistically signiﬁcant differences compared to PB pre-treatment (0.9% NaCl or
B):  p < 0.01.
† Statistically signiﬁcant differences between PB treated and untreated cultures:
 < 0.05.
†† Statistically signiﬁcant differences between PB treated and untreated cultures:
 < 0.01.Statistically signiﬁcant differences compared to the control (NaCl, 0.9%): p < 0.05.
† Statistically signiﬁcant differences between PB treated and untreated cultures:
p  < 0.05.
micronucleated cells can suggest cytotoxic effects corroborated by
the decrease in the survival rates and in the mitotic index.
Moreover, a decrease in hepatocyte ploidy levels was observed.
There was no signiﬁcant difference in the level of chromosomal
aberrations found for the negative control (0.9% NaCl) and the PB-
treated cultures (Table 4). However, pre-treatment with PB did lead
to increased levels of chromosomal aberrations, which were statis-
tically signiﬁcant (p < 0.05) at an NDEA concentration of 105 g/mL.
3.2. Gene expression of CYP
Using real-time PCR the gene expression of CYP2A1, CYP2B1,
CYP2B2 and CYP2E1 was determined upon the application ofFold induction of rat CYP genes following administration of NDEA.
Gene Assay conditions Mean fold induction of
control ± SEM
W/o  PB
CYP2A1 NaCl 0.9% 1.38 ± 0.09 1.01 ± 0.36
NDEA 0.21 g/mL 1.40 ± 0.20 0.74 ± 0.17†
NDEA 2.1 g/mL 1.41 ± 0.14 0.38 ± 0.07*,†
NDEA 21 g/mL 0.81 ± 0.24 0.71 ± 0.09
NDEA 105 g/mL 0.79 ± 0.53 0.48 ± 0.18
CYP2B1 NaCl 0.9% 0.84 ± 0.13 6.80 ± 0.60†
NDEA 0.21 g/mL 2.14 ± 0.03* 7.13 ± 0.24†
NDEA 2.1 g/mL 0.98 ± 0.33 7.13 ± 0.22†
NDEA 21 g/mL 0.98 ± 0.30 7.42 ± 0.38†
NDEA 105 g/mL 0.60 ± 0.24 6.35 ± 0.36†
CYP2B2 NaCl 0.9% 0.85 ± 0.06 1.95 ± 0.25†
NDEA 0.21 g/mL 2.40 ± 0.23* 2.09 ± 0.10
NDEA 2.1 g/mL 1.29 ± 0.15* 1.70 ± 0.29
NDEA 21 g/mL 1.58 ± 0.24* 2.35 ± 0.17†
NDEA 105 g/mL 0.49 ± 0.12* 2.86 ± 0.34†
CYP2E1 NaCl 0.9% 0.72 ± 0.23 0.50 ± 0.21
NDEA 0.21 g/mL 1.86 ± 0.15* 0.24 ± 0.03†
NDEA 2.1 g/mL 1.50 ± 0.20* 0.32 ± 0.01†
NDEA 21 g/mL 1.14 ± 0.10* 0.16 ± 0.05†
NDEA 105 g/mL 0.77 ± 0.22 0.21 ± 0.01†
Mean ± SEM of 3 female Fischer 344 rat livers. Results are reported as fold induction
standardized to the house keeping gene (18S), for mRNA levels of CYPs.
* Statistically signiﬁcant differences compared to the control (NaCl, 0.9%): p < 0.05.
† Statistically signiﬁcant differences between PB treated and untreated cultures:
p  < 0.05.
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Table 5). It is surprising that short-treatment (3 h) of hepatocytes
ith low NDEA concentration (0.21 g/mL) induces signiﬁcant
ncreases in CYP mRNA levels (i.e. 3-fold for CYP2B1 and 2B2; 2.5-
old for CYP2E1) (Table 5). These effects are even higher than those
bserved on CYP2B2 mRNA after longer treatment (16 h) with 1 mM
B (in the absence of NDEA).
Notably, PB treatment alone induced a signiﬁcant increase in
YP2B1 (∼8-fold) and CYP2B2 (∼2-fold) mRNA. Treatment with
DEA after pre-exposure to PB led to signiﬁcant increases in the
evels of CYP2B1 mRNA at all the NDEA concentrations tested,
hereas the CYP2B2 levels were higher at 21 and 105 g/mL NDEA.
owever, although the levels were found to be higher, no sig-
iﬁcantly synergistic effect was identiﬁed for the treatment. The
xpression of CYP2A1 and CYP2E1 was shown to be signiﬁcantly
educed (about 2- and 7-fold, respectively), suggesting the antag-
nistic effect between PB and NDEA. The use of pentobarbital as
n anesthetic did not inﬂuence mRNA expression since no statis-
ical differences were found in the control group of rats that were
uthanized in a CO2 chamber. The basal levels, corresponding to
he values measured after 3 h platting after sacriﬁce, for mRNA
xpression of CYP2A1, CYP2B1, CYP2B2, and CYP2E1 were 1.36,
.70, 2.17 and 0.58-fold compared to NDEA-untreated cultures.
his indicates that pentobarbital can inﬂuence the analyzed CYPs
xpression.
. Discussion
The inhibition of apoptosis is considered a key event in the action
echanism for the development of rat liver tumors triggered by PB
Holsapple et al., 2006; Deguchi et al., 2009). Several studies have
uggested that PB can enhance cell proliferation by the inhibition of
poptosis (Mills et al., 1995; Schulte-Hermann et al., 1995). How-
ver, another study demonstrated that PB was also able to induce
poptosis in an in vitro model at a concentration of 1 mM,  was
ssociated with the over-expression of c-myc oncogene, and was
ax-dependent (Osanai et al., 1997).
Our results demonstrate that pre-treatment with PB and NDEA
nduced a dose-response increase in the apoptosis rate (Table 2)
uggesting the removal of damaged cells. This mechanism is
upported by the observation that the remaining surviving cells
Table 2) and the mitotic indices decreased. This could lead to
n arrest in the cell cycle that contributes towards DNA repair
Table 3). Furthermore, decreased levels of micronucleated cells
ay  not necessarily be interpreted as having a protective effect.
uch an assumption would only hold true if there were no inﬂu-
nce on cell proliferation, since mitosis is a prerequisite for the
ormation of micronuclei. Whenever the rate of mitosis (mitotic
ndex) is reduced, fewer micronucleated cells become visible, even
fter higher damage, leading to a masking of the actual effect. In our
xperiments, both the mitotic indices and the levels of micronucle-
ted cells decreased upon PB pre-treatment. Taking the increased
evels of necrosis and apoptosis into account, it seems more likely
hat PB pre-treatment induced the cytochromes responsible for
he formation of the reactive metabolite. However, when analyz-
ng the damage at the chromosomal level, increased numbers of
berrations were found which were signiﬁcant at the highest NDEA
oncentration used, indicating that PB treatment enhanced the for-
ation of the reactive metabolite(s).
The mitotic index should be appraised in conjunction with the
ate of micronucleus induction. At higher doses of NDEA, mam-
alian cells arrest at the transition from G1 to S phase (G1-Sheckpoint) and G2 to M phase (G2-M checkpoint) in response to
NA damage. Cell cycle arrest at these checkpoints prevents DNA
eplication and mitosis in the presence of DNA damage. For this rea-
on, no dose-response effect could be observed. The inactivation ofters 206 (2011) 139– 143
these cell cycle checkpoints results in genomic instability, which is
closely associated with cell transformation and tumorigenesis.
It is widely accepted that the mutagenic action of nitrosamines
is mediated via their immediate metabolic product (Verna et al.,
1996). The metabolism of NDEA in vivo results in the formation
of electrophilic reactive intermediates, free radicals, and associ-
ated oxidative stress (Parke, 1987; Shiota et al., 2002), which are in
turn able to alkylate lipids, proteins, and genetic materials. Among
its many effects as a potent tumor promoting agent, PB can cause
oxidative damage to livers in response to the induction of certain
cytochrome P450 enzymes (Imaoka et al., 2004). Wastl et al. (1998)
demonstrate in preneoplastic and neoplastic mouse liver lesions
that PB is a potent inducer of CYP2A5, and is likewise involved in
NDEA metabolism, suggesting that it may  play an important role in
the development of liver cancer and may  be used as a marker for
spontaneous and NDEA-induced mouse liver foci. In the present
work we  did not investigate the effects on mouse CYP2A5 (an
ortholog of human CYP2A6). Several genetic models of carcinogen-
esis indicate that progression to carcinoma involves the activation
of proto-oncogenes and an additional event involving the dele-
tion or inactivation of a suppressor gene (Osanai et al., 1997). The
described mechanisms of proto-oncogene activation include point
mutations and gross DNA rearrangements, such as translocations
and gene ampliﬁcation (Slenman and Sager, 1987; Sargent et al.,
1996). In the present study an increasing number of dicentric chro-
mosomes was observed for both treatments, especially involving
the largest chromosomes. This might suggest that the ras proto-
oncogene, located on chromosome 1, is involved in the carcinogenic
process (Sargent et al., 1996).
NDEA was also found to induce more CYP2B2 than CYP2B1,
but when PB was used as a CYP inducer, the levels of CYP2B1
were higher than those of CYP2B2. The results obtained for the
phenobarbital-induction of CYP2B1 and CYP2B2 mRNAs in cultured
rat hepatocytes reﬂect the situation found in vivo, in that CYP2B1
mRNAs are more inducible than CYP2B2. The same was  already
described for Valproate, an anti-epileptic drug (Rogiers et al., 1995).
Measurements of cell viability are very important when the
objective is RNA expression, since a decrease in the number
of cells can be problematic for down-regulated genes. Another
problem correlated to cytotoxic effects is the decrease in the
micronucleus index, and the absence of any dose-response, as
related before. Meanwhile, the induction of cytotoxicity may be
observed with many carcinogens, and this fact may  be read as
a compensatory hyperplasia that contributes to the observed
tumorigenicity induced by NDEA. The number of viable cells in
the W/o  group did not vary signiﬁcantly. However, if we  con-
sider that 2000 cells were analyzed per animal/NDEA group
concentration (i.e. 2000 cells, 3 animals, 4 concentrations, in the
presence and absence of PB) in duplicate, the values are signiﬁ-
cant for such individual parameters as the rates of apoptosis and
necrosis.
Although some previous publications (Weisburger et al., 1975;
OıˇConnor et al., 1988) demonstrated that PB is capable of decreas-
ing NDEA carcinogenesis we considered that PB modiﬁes the
metabolism of a number of chemical carcinogens as well is able
to enhances production of detoxiﬁcation products in contrast to
reactive electrophilic carcinogenic intermediates. Weisburger et al.
(1975) reported that phenobarbital decreased the carcinogene-
sis potency of NDEA. In their work, NDEA was administered in
drinking water (40 ppm) for 10 weeks with PB (500 ppm) lead-
ing to the development of liver cancer in 19 of 30 rats. PB was
administered after the ﬁrst week of NDEA treatment. The present
data show genotoxic alterations when PB was  added in the cul-
ture prior to NDEA. OıˇConnor et al. (1988) have shown that PB
in drinking water at 0.05% increase the rate of repair of O6-
methylguanine from the hepatic DNA rats given NDMA, and not
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DEA. Although NDEA can induce the same pattern of DNA damage,
he authors did not observe the same results for in vitro experi-
ents.
. Conclusions
This manuscript reports information on the potential role of
henobarbital on N-nitrosodiethylamine genotoxicity. To this end,
ytotoxic and genotoxic effects of N-nitrosodiethylamine and/or
henobarbital have been evaluated in rat hepatocyte cultures
nd correlated with changes in CYP expression. Although the
opic is not new, as the role of CYP-dependent bioactivation in
enotoxic/cytotoxic effects of nitrosamine derivatives has been
reviously studied, the paper contains some ﬁndings which com-
lete previous studies.
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